Compare Amphastar Pharmaceuticals Inc (AMPH) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Old Dominion Freight Line Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Old Dominion Freight Line Inc trades at $227.74 (market cap $47.34B). The key difference: Old Dominion Freight Line Inc is far larger — about 57.3× Amphastar Pharmaceuticals Inc's market cap, and Old Dominion Freight Line Inc pays a 0.51% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | ODFL | |
|---|---|---|
Market Cap | $826.08M | $47.34B |
Sector | Health | Industrials |
52-Week High | $30.81 | $248.73 |
52-Week Low | $16.87 | $126.29 |
Enterprise Value | $1.22B | $47.09B |
Dividend Yield | — | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
ODFL trades at $227.63, up 0.79% today, near its consensus price target of $231.29. The stock shows bullish technical signals with strong moving averages, though RSI indicates mild overbought conditions. Fundamentally, ODFL maintains high profitability with an 18.46% net margin and 23.33% ROE, but valuation ratios like P/E of 47.52 are elevated. Recent earnings beats and a solid balance sheet with minimal debt support its quality, while news highlights mixed sentiment amid freight market recovery and competitive pressures from Amazon's LTL expansion.
Outlook: ODFL offers a high-quality play on freight recovery with robust fundamentals, but rich valuation and near-term headwinds warrant caution. Upside depends on Q2 2026 earnings meeting the $1.51 EPS estimate. Risks include economic sensitivity and rising competition. Analyst consensus is mixed with 33% buy ratings, suggesting patience for better entry points may be prudent.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
